ALX Oncology
ALXO
ALXO
76 hedge funds and large institutions have $160M invested in ALX Oncology in 2023 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 23 increasing their positions, 22 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
3.03% less ownership
Funds ownership: 83.91% → 80.88% (-3%)
38% less capital invested
Capital invested by funds: $258M → $160M (-$97.8M)
Holders
76
Holding in Top 10
1
Calls
$1.01M
Puts
$61K
Top Buyers
1 | +$1.07M | |
2 | +$435K | |
3 | +$260K | |
4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$218K |
5 |
HSBC Holdings
London,
United Kingdom
|
+$168K |
Top Sellers
1 | -$3.75M | |
2 | -$2.59M | |
3 | -$931K | |
4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$877K |
5 |
Goldman Sachs
New York
|
-$233K |